SAGITTARIUS Participates in the Second Diagnosis and Treatment Refractory Cancers Cluster Annual Meeting
The meeting reaffirmed the Cluster’s commitment to fostering synergies between projects.
The meeting reaffirmed the Cluster’s commitment to fostering synergies between projects.
Science meets people in Milan.
2-5 July – Barcelona (Spain)The ESMO Gastrointestinal Cancers Congress (ESMO GI) 2025, held in Barcelona, brought together leading clinicians, researchers, and patient advocates to discuss the latest advances in gastrointestinal […]
From 2–4 July 2025, Digestive Cancers Europe (DiCE) hosted its General Assembly and 10th Annual Masterclass in Barcelona, Spain, marking a decade of collective learning, collaboration, and patient advocacy across […]
An editorial from SAGITTARIUS trial’s Study Chair, Clara Montagut Viladot, Head of the Gastrointestinal Cancer Section in the Oncology Department at Hospital del Mar (Barcelona)
Liquid biopsy under the spotlight on May 22 in Milan during the Symposium “mCRC – Comprendere l’eterogeneità e l’evoluzione del carcinoma colorettale metastatico: dai meccanismi alle terapie”
The SAGITTARIUS clinical trial was presented with a dedicated poster at one of the world’s most prestigious conferences in oncology.
An editorial from SAGITTARIUS project’s Scientific Coordinator, Silvia Marsoni M.D. Ph.D., Head of the Precision Oncology Unit, IFOM ETS – AIRC Institute of Molecular Oncology
The first six patients have been enrolled in the Sagittarius clinical trial.
On the 12th of September, SAGITTARIUS experts joined the first Annual Cluster Meeting of the EU Cancer Mission “Diagnosis and Treatment” Cluster.